전체메뉴 닫기

About

Vision
& Mission

History

Corporate
Identity

Subsidiaries

Directions

Business

Overview

i-Cord Cord Blood Bank

Bio Insurance

CHAUM

IT

CDMO

Overview of Matica BioLabs

Consulting

Genomics

R&D: Pipelines

Investors: Business Performance; IR
Presentations

ESG

ESG
Management

Environmental

Social

Governance

Articles of Incorporation

Board of Directors

Business Performance

IR
Presentations

Business Performance

Investors

IR
Presentations

Please Download the Latest IR Materials

[3Q 2026] Business Highlights

2026.11.13

Views: 17

This presentation provides an overview of CHA Biotech's financial performance and key business highlights for the third quarter of 2026.

Attached File

[CHA Biotech] 3Q 2026 Business Highlights(2026.11.13).pdf

Previous Post

No previous posts

Next Post

[2026.2Q] Business Performance Results

2026.08.13

View List

CHA Network

Company Name CHA Biotech Co., Ltd.
CEO Won Tae Cha

[Main Office] CHA Bio Complex, 335 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488, Korea

TEL: +82-31-881-7400
FAX: +82-31-881-7524
IR Hotline: +82-31-780-7418

[Head Office] P&FOLUS Building, 442 Dosan-daero, Gangnam-gu, Seoul, Korea
[Business Hours] 09:00 AM – 06:00 PM

COPYRIGHT ⓒ 2025 CHA Biotech, All rights reserved.

Global Healthcare

Related

Business